Literature DB >> 21778026

Impact of an assisted reassessment of antibiotic therapies on the quality of prescriptions in an intensive care unit.

L Bornard1, J Dellamonica, H Hyvernat, F Girard-Pipau, N Molinari, A Sotto, P-M Roger, G Bernardin, C Pulcini.   

Abstract

OBJECTIVES: The study's objective was to assess the impact of a professional multifaceted intervention designed to improve the quality of inpatient empirical therapeutic antibiotic courses at the time of their reassessment, i.e. 24 to 96 hours after treatment initiation.
DESIGN: We conducted a 5-month prospective pre- and post-intervention study in a medical Intensive Care Unit (ICU) in a teaching hospital, using time-series analysis. The intervention was a multifaceted professional intervention combining systematic 3-weekly visits of an infectious diseases specialist to discuss all antibiotic therapies, interactive teaching courses, and daily contact with a microbiologist.
RESULTS: Eighty-one antibiotic prescriptions were assessed, 37 before and 44 after the intervention. The prevalence of adequate antibiotic prescriptions was high and not statistically different before and after the intervention (73% vs. 80%, P=0.31), both for sudden change (P=0.67) and linear trend (P=0.055), using interrupted time-series analysis. The intervention triggered a more frequent reassessment of the diagnosis between day 2 and day 4 (11% vs. 32%, P=0.02) and slightly improved the adaptation of antibiotic therapies to positive microbiology (25% before vs. 50% after, P=0.18).
CONCLUSIONS: Our multifaceted intervention may have improved the quality of antibiotic therapies around day 3 of prescription, but the difference did not reach statistical significance, possibly because of a ceiling effect.
Copyright © 2011 Elsevier Masson SAS. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21778026     DOI: 10.1016/j.medmal.2010.12.022

Source DB:  PubMed          Journal:  Med Mal Infect        ISSN: 0399-077X            Impact factor:   2.152


  6 in total

Review 1.  Infectious diseases consultations can make the difference: a brief review and a plea for more infectious diseases specialists in Germany.

Authors:  Siegbert Rieg; Marc Fabian Küpper
Journal:  Infection       Date:  2016-02-23       Impact factor: 3.553

2.  Clinical outcomes in patients admitted to a hospitalist service exposed to an antimicrobial stewardship program - a retrospective matched cohort study.

Authors:  E Rennert-May; J Conly; G Chen; B Dalton
Journal:  Antimicrob Resist Infect Control       Date:  2019-05-24       Impact factor: 4.887

3.  An antimicrobial stewardship program improves antimicrobial treatment by culture site and the quality of antimicrobial prescribing in critically ill patients.

Authors:  Christina M Katsios; Lisa Burry; Sandra Nelson; Tanaz Jivraj; Stephen E Lapinsky; Randy S Wax; Michael Christian; Sangeeta Mehta; Chaim M Bell; Andrew M Morris
Journal:  Crit Care       Date:  2012-11-05       Impact factor: 9.097

4.  Impact of a Prospective Audit and Feedback Antimicrobial Stewardship Program at a Veterans Affairs Medical Center: A Six-Point Assessment.

Authors:  Haley J Morrill; Aisling R Caffrey; Melissa M Gaitanis; Kerry L LaPlante
Journal:  PLoS One       Date:  2016-03-15       Impact factor: 3.240

5.  Mapping the decision pathways of acute infection management in secondary care among UK medical physicians: a qualitative study.

Authors:  Timothy Miles Rawson; Esmita Charani; Luke Stephen Prockter Moore; Bernard Hernandez; Enrique Castro-Sánchez; Pau Herrero; Pantelis Georgiou; Alison Helen Holmes
Journal:  BMC Med       Date:  2016-12-12       Impact factor: 8.775

6.  The impact of antimicrobial stewardship program designed to shorten antibiotics use on the incidence of resistant bacterial infections and mortality.

Authors:  Ling-Ju Huang; Su-Jung Chen; Yu-Wen Hu; Chun-Yu Liu; Ping-Feng Wu; Shu-Mei Sun; Shih-Yi Lee; Yin-Yin Chen; Chung-Yuan Lee; Yu-Jiun Chan; Yueh-Ching Chou; Fu-Der Wang
Journal:  Sci Rep       Date:  2022-01-18       Impact factor: 4.379

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.